---
id: 164
title: Human Herpesvirus 6 (HHV-6)
category: organisms
subcategory: herpesviruses
tags: [HHV-6, roseola, sixth-disease, encephalitis, transplant, ganciclovir, foscarnet]
difficulty: medium
---

## Question

What are the key clinical syndromes of HHV-6? Use the **"Roseola (Kids), Reactivation in Transplant (Encephalitis) → Ganciclovir/Foscarnet"** framework.

## Answer

### **Human Herpesvirus 6 (HHV-6) Overview:**

**Subtypes:**
- **HHV-6B:** Causes primary infection (roseola infantum)
- **HHV-6A:** Less common, pathogenicity unclear

**Epidemiology:**
- **Primary infection** by age 2-3 years (>90% seropositive)
- **Latency:** Establishes lifelong latency (monocytes, lymphocytes, CNS)
- **Reactivation:** Immunocompromised (transplant, HIV)

### **Clinical Syndromes:**

**Roseola Infantum (Exanthem Subitum, Sixth Disease) - Primary Infection:**

**Presentation:**
- **Age:** 6-24 months (peak 6-12 months)
- **High fever** (39-40°C) × 3-5 days (often only symptom)
- **Fever abruptly resolves** → **rash appears** (as fever breaks)
- **Rash:** Pink, maculopapular (trunk → spreads to neck/extremities), blanching, non-pruritic, lasts 1-2 days
- **Febrile seizures** common (10-15%) due to high fever

**Other Primary Infection Manifestations:**
- **Asymptomatic** (many cases)
- **Febrile illness** without rash

**Reactivation in Transplant Recipients:**

**Encephalitis (Most Serious):**
- **Stem cell transplant** (especially cord blood transplant) - highest risk
- **Timing:** 2-6 weeks post-transplant
- **Presentation:** Confusion, memory impairment, seizures, altered mental status
- **MRI:** Temporal lobe involvement (mimics HSV encephalitis)
- **CSF:** Lymphocytic pleocytosis, ↑protein, HHV-6 PCR positive
- **Mortality:** 30-50% if untreated

**Other Transplant Manifestations:**
- **Fever, rash** (maculopapular)
- **Bone marrow suppression** (delayed engraftment in HSCT)
- **Hepatitis** (↑transaminases)
- **Pneumonitis** (rare)

**Chromosomally Integrated HHV-6 (ciHHV-6):**
- **HHV-6 DNA integrated** into host chromosomes (inherited)
- **1% of population**
- **High viral loads** in blood (present in all nucleated cells)
- **NOT active infection** (requires differentiation from reactivation)
- **Diagnosis:** Persistent high viral load (>5.5 log copies/mL) in whole blood, hair follicles positive (vs. plasma/CSF for active infection)

### **Diagnosis:**

**Roseola (Primary Infection):**
- **Clinical diagnosis** (high fever × 3-5 days → rash as fever breaks)
- **Serology:** IgM anti-HHV-6 (acute), 4-fold IgG rise (convalescent)

**Reactivation/Encephalitis:**
- **PCR (quantitative):** Blood, CSF
  - **Active infection:** Plasma PCR positive, rising viral loads
  - **ciHHV-6:** Whole blood persistently positive (>5.5 log), plasma often negative
- **MRI brain:** Temporal lobe signal abnormalities (encephalitis)

**Differentiating Active Infection from ciHHV-6:**
- **ciHHV-6:** Stable high viral load (whole blood), hair follicles positive, no clinical syndrome
- **Active infection:** Rising viral load (plasma), clinical syndrome (encephalitis, fever), CSF positive

### **Treatment:**

**Roseola (Immunocompetent Children):**
- **Supportive care ONLY**
- **Antipyretics** for fever
- **Self-limited**

**Reactivation in Transplant (Encephalitis, Severe Disease):**

**Ganciclovir:**
- **5 mg/kg IV q12h × 2-3 weeks** (or until viral clearance)
- **First-line** (in vitro activity)

**Foscarnet:**
- **90 mg/kg IV q12h** (or 60 mg/kg IV q8h) × 2-3 weeks
- **Alternative** (if ganciclovir resistance or intolerance)
- **Nephrotoxic** (hydration, monitor renal function)

**Reduce Immunosuppression:**
- **Taper IS** if possible

**Evidence:**
- **Limited data** (case series, no RCTs)
- **Encephalitis often fatal** without treatment

**ciHHV-6:**
- **NO treatment** (not active infection)

## Key Points

### **Roseola = "Fever Then Rash":**
- **High fever × 3-5 days** → fever breaks → **rash appears**
- **Infants 6-24 months**
- **Febrile seizures common** (10-15%)
- **Self-limited**, supportive care

### **Encephalitis in Transplant:**
- **Stem cell transplant** (especially cord blood) - highest risk
- **Confusion, memory impairment, seizures** (2-6 weeks post-transplant)
- **MRI:** Temporal lobe involvement (mimics HSV)
- **Treat with ganciclovir or foscarnet**

### **Chromosomally Integrated HHV-6 (ciHHV-6):**
- **1% of population**
- **High persistent viral load** (whole blood, hair follicles)
- **NOT active infection** (no treatment needed)
- **Distinguish from reactivation:** Stable viral load, no clinical syndrome

### **Ganciclovir = First-Line:**
- **5 mg/kg IV q12h** for transplant reactivation/encephalitis
- **Foscarnet** alternative (nephrotoxic)

### **Bone Marrow Suppression:**
- **Delayed engraftment** in HSCT (reactivation impairs marrow recovery)
- **Consider preemptive treatment** if high viral loads early post-transplant

### **Clinical Pearls:**
- **Roseola:** High fever × 3-5 days → rash as fever breaks (infants 6-24 months)
- **Transplant encephalitis:** Confusion/seizures 2-6 weeks post-SCT → ganciclovir/foscarnet
- **ciHHV-6:** Persistent high viral load (whole blood, hair follicles) = inherited, NOT active infection
- **MRI:** Temporal lobe involvement (mimics HSV encephalitis)
- **Febrile seizures** common in roseola (high fever)

## Sources

- [AST: HHV-6 in Transplant 2024]
- [AAP: Roseola Infantum 2024]

## Media

N/A
